Our Team

TILT’s founder and CEO, Akseli Hemminki is a biotech entrepreneur and cancer clinician who has personally treated almost 300 patients with ten different oncolytic viruses. Akseli leads a team of experienced industry professionals who collectively have decades of experience in the research, development, and commercialization of cancer therapeutics

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Chairman of the Board

Aino Kalervo

MSc, MS, Chief Business Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

Víctor Cervera-Carrascón

M.Pharm, Head of Immunology

Riikka Havunen

PhD, Head of R&D

Riikka Kalliokoski

Bachelor of Social and Health Care, Lab manager

João Manuel Santos

MSc, Head of Cell Therapy

no image

Suvi Sorsa

PhD, Head of Clinical Research

Remi Gloeckler

PhD, CMC Advisor